股票骗局有哪些-中信证券app-【东方资本】,a股交易t 几,t0开通条件,专业线上配资

科學文獻

我們與學術機構開展合作研究，以評估我們的管線產品。以下是發表的相關文獻。

年：

Plain language summary of the CARTITUDE-4 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma

Jesús San-Miguel, Binod Dhakal, Nitin Patel, Jordan M. […]

Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma

Doris K Hansen, Binod Dhakal, Mehdi Hamadani, David Din […]

Cilta-cel, a BCMA-targeting CAR-T therapy for patients with multiple myeloma

Sundar Jagannath, Carolyn C Jackson, Jordan M Schecter, […]

Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma

Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, […]

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

Jie Xu, Bai-Yan Wang, Shan-He Yu, Shi-Jun Chen, Shuang- […]

本網站使用Cookies來改善您的整體體驗，讓您下次訪問網站時更加輕松快捷，為您帶來更好的服務。具體內容請參閱隱私政策 Cookie政策。